GLP-1 receptor agonists are best known for treating type 2 diabetes and obesity, yet a growing body of evidence suggests their benefits may extend well beyond metabolic disease to dermatologic indications. “GLP-1s are the surprise anti-inflammatory that no one saw coming,” Mona Shahriari, MD, FAAD, associate clinical professor of dermatology at Yale University School of Medicine, told

GLP-1s are known for weight loss. A physician reviews 7 evidence-backed benefits, from kidney and liver disease to sleep apnea, addiction, clots and cancer progression.

NEW YORK — Using a GLP-1 receptor agonist may lead to a wide range of psychiatric effects, and psychological support is an important part of patient management, according to a…